Apollo Endosurgery, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Apollo Endosurgery, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2022.
  • Apollo Endosurgery, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $76.7M, a 9.52% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $76.7M +$6.67M +9.52% Dec 31, 2022 10-K 2023-03-30
Q4 2021 $70.1M +$6.81M +10.8% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $63.2M +$4.19M +7.1% Dec 31, 2020 10-K 2022-02-22
Q4 2019 $59M +$6.82M +13.1% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $52.2M +$10.3M +24.6% Dec 31, 2018 10-K 2020-03-26
Q4 2017 $41.9M -$10.9M -20.6% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $52.8M +$10.9M +26% Dec 31, 2016 10-K 2018-03-01
Q4 2015 $41.9M +$10.6M +34% Dec 31, 2015 10-K 2017-03-24
Q4 2014 $31.3M +$7.04M +29% Dec 31, 2014 10-K 2016-03-22
Q4 2013 $24.2M +$2.74M +12.7% Dec 31, 2013 10-K 2015-03-24
Q4 2012 $21.5M +$1.98M +10.2% Dec 31, 2012 10-K 2014-03-18
Q4 2011 $19.5M Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.